Canada markets closed

Avadel Pharmaceuticals plc (AVDL)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
18.09+0.79 (+4.57%)
At close: 04:00PM EDT
18.09 0.00 (0.00%)
After hours: 04:17PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
27,963
27,963
0
0
22,334
Cost of Revenue
846
846
0
0
5,742
Gross Profit
27,117
27,117
0
0
16,592
Operating Expenses
Research Development
13,261
13,261
20,700
17,104
20,442
Selling General and Administrative
151,705
151,705
74,516
68,495
32,405
Total Operating Expenses
164,966
164,966
95,216
85,599
53,253
Operating Income or Loss
-137,849
-137,849
-95,216
-85,599
-36,661
Interest Expense
9,886
9,886
12,342
9,942
12,994
Total Other Income/Expenses Net
-13,042
-13,042
-3,881
2,396
44,573
Income Before Tax
-160,777
-160,777
-111,439
-93,145
-5,082
Income Tax Expense
-501
-501
26,025
-15,816
-12,110
Income from Continuing Operations
-160,276
-160,276
-137,464
-77,329
7,028
Net Income
-160,276
-160,276
-137,464
-77,329
7,028
Net Income available to common shareholders
-160,276
-160,276
-137,464
-77,329
7,028
Basic EPS
-2.15
-
-2.29
-1.32
0.13
Diluted EPS
-2.15
-
-2.29
-1.32
0.13
Basic Average Shares
73,273
-
60,094
58,535
52,996
Diluted Average Shares
73,273
-
60,094
58,535
54,941